top of page

Get a Second Opinion Without Medical Travel: Online Access to Top Pulmonary Oncologists in the USA

Author: Medical Editor Iris


Content




When Pulmonary Cancer Treatment at Home Isn’t Enough

If you or your loved one have been diagnosed with pulmonary cancer and have already undergone treatments at your country’s top hospitals, yet your condition isn’t improving, the situation can feel overwhelming. You may face:

  • Local surgeons saying surgery isn’t possible due to tumor complexity

  • Limited access to the latest targeted therapy or immunotherapy

  • Conflicting treatment advice from different doctors

  • Long wait times that could delay treatment progress

These frustrations often push patients to look abroad for solutions — and the USA remains a global leader in pulmonary oncology.


Why the USA Is Ranked Among the Best for Pulmonary Oncology Care

The United States is home to top pulmonary oncologists USA and world-class cancer hospitals, combining advanced technologies, breakthrough medications, and multidisciplinary expertise.

Leading hospitals include:

  • MD Anderson Cancer Center – Pioneers in targeted therapy, genetic testing, and clinical trials for pulmonary cancer.

  • Memorial Sloan Kettering Cancer Center (MSKCC) – Leaders in minimally invasive thoracic surgery and personalized pulmonary oncology.

  • Dana-Farber Cancer Institute – Harvard-affiliated, globally recognized for immunotherapy innovations.

  • Mayo Clinic – Famous for coordinated, patient-centered pulmonary cancer care.


Medical Travel for Pulmonary Cancer Treatment in the USA vs. Staying Home

Traveling to the USA for pulmonary cancer treatment ensures direct access to the world’s best doctors and advanced technology but it can be expensive, exhausting, and time-consuming.

This raises a vital question:


Can you benefit from the expertise of top USA pulmonary oncologists without medical travel?


The Answer: Online and Virtual Second Opinions

Yes — through an online second opinion or virtual second opinion, you can have your medical case reviewed by top pulmonary oncologists USA without leaving your home. This enables you to:

  • Confirm or refine your diagnosis

  • Learn about advanced treatment options not available locally

  • Receive a clear action plan from experts who treat complex pulmonary cancer cases daily


Real Case: From Beijing to Boston — A Patient’s Journey to Advanced Pulmonary Cancer Care

Mr. Zhang, a 58-year-old mechanical engineer from Beijing, had been living a healthy life until he began experiencing persistent coughing and shortness of breath. After a CT scan revealed a large mass in his right upper lung, further tests confirmed stage III non-small cell pulmonary cancer (NSCLC).

The tumor was located adjacent to major blood vessels, making surgery extremely risky. Local oncologists recommended chemotherapy and radiation, but the expected response rate was low, and they ruled out surgical removal entirely.


Step 1: Accessing a Virtual Second Opinion from the USA


Through Medebound HEALTH, Mr. Zhang submitted his imaging scans, biopsy results, and genetic profiling (EGFR, ALK, PD-L1 tests). Within 10 days, he had a virtual second opinion from a Harvard-affiliated pulmonary oncologist at Dana-Farber Cancer Institute.

The U.S. specialist carefully reviewed his genetic testing and found that his tumor carried an EGFR exon 19 deletion mutation  making him an ideal candidate for targeted therapy rather than traditional chemotherapy.


Step 2: A Tailored Advanced Treatment Plan


Instead of starting with chemotherapy, the specialist recommended:

  1. Osimertinib (Tagrisso) – a third-generation EGFR inhibitor with high precision targeting, known to penetrate brain tissue and reduce recurrence risk.

  2. Close monitoring with PET-CT scans every 6 weeks to measure tumor shrinkage.

  3. Robotic-assisted thoracic surgery after the tumor is reduced in size, offering less pain, smaller incisions, and faster recovery compared to open surgery.

This combination aimed to shrink the tumor enough to make it operable, while avoiding the side effects of conventional chemotherapy.


International pulmonary cancer patient receiving targeted therapy and robotic-assisted surgery at a top U.S. cancer center, arranged by Medebound HEALTH
Mr. Zhang’s successful pulmonary cancer treatment journey from targeted therapy to robotic-assisted surgery coordinated by Medebound HEALTH. Images are blurred to protect patient privacy.


Step 3: Transition from Virtual Care to Medical Travel

Encouraged by this new hope, Mr. Zhang opted for medical travel to Boston for direct care. Medebound HEALTH arranged:

  • Expedited hospital appointment in 3 weeks (vs. typical 6–8 weeks)

  • Visa support and travel coordination

  • Medical + daily life translation so he could navigate both hospital and city without stress


Step 4: Successful Outcome

After 8 weeks of targeted therapy, follow-up PET-CT scans showed a 30% reduction in tumor size and no signs of spread. The surgical team at Dana-Farber proceeded with robotic-assisted lobectomy.

  • The operation preserved healthy lung tissue

  • Minimal blood loss and faster healing

  • Discharge within 5 days

Pathology confirmed complete removal of the tumor with clear margins. Mr. Zhang returned to Beijing after a short recovery, continuing maintenance therapy with Osimertinib to prevent recurrence.



Key Takeaways from This Case

  • Genetic profiling opened the door to targeted drugs unavailable locally.

  • Virtual second opinion provided an accurate, individualized treatment plan within 10 days.

  • Medical travel enabled access to advanced surgery and technology.

  • The combination of precision medicine + robotic surgery resulted in a successful, cancer-free outcome.


Top U.S. Hospitals for Pulmonary Cancer Care Asian Patients Can Trust in 2025


These institutions lead the 2025–2026 U.S. News & World Report cancer rankings and are globally respected for their pulmonary cancer expertise and interdisciplinary treatment approaches. Each offers services tailored to the unique needs of Asian patients.

1. MD Anderson Cancer Center (Houston, TX) – Ranked #1 in Cancer Care (2025–26)


Why it stands out:

  • Multidisciplinary Thoracic Center offers personalized care across all pulmonary cancer stages even for cases deemed untreatable elsewhere.

  • Technology includes VATS (Video-Assisted Thoracic Surgery), proton therapy, and tailored radiation options like VMAT, IMRT, and SBRT, plus clinical trials for novel therapies.


Asian patient–friendly services:

  • International Center offers multilingual interpreters, particularly in Mandarin, plus visa support, travel logistics, and in-campus assistance.

  • Active global collaborations, including partnerships with Indian institutions, enhance research and cultural understanding.


2. Memorial Sloan Kettering Cancer Center (NY, NY) – Ranked #2 Nationally


Why it stands out:

  • Advanced personalized medicine surgery, targeted chemotherapy, immunotherapy, radiation, and interventional radiology are integrated into disease-specific programs.

  • Performs over 1,200 pulmonary cancer operations annually, with a majority being minimally invasive.

Asian patient–friendly services:

  • Offers medical interpretation in Chinese, Korean, and Japanese and translations of medical documents.

  • Runs the Chinese American Cancer Care Access Program, focused on culturally effective support and navigation.

  • Has mobile and community outreach (e.g., in Mandarin), improving accessibility and trust.

3. Dana-Farber Brigham Cancer Center (Boston, MA) – Ranked #3

Why it stands out:

  • A leading facility for both non-small cell and small cell pulmonary cancers. Offers genetics-based personalized therapies, minimally invasive surgery, and advanced radiation (e.g., IMRT, SBRT, radiosurgery).

  • Boasts strong affiliation with an NCI-designated comprehensive cancer research ecosystem.

Asian patient–friendly services:

  • Provides free professional interpretation in Mandarin, Cantonese, Korean, and Japanese.

  • Home to the Chen-Huang Center for EGFR-Mutant Lung Cancers, one of the world’s few clinics specializing in EGFR-mutant pulmonary cancer common in Asian patients.



4. Mayo Clinic – Rochester (Rochester, MN) – Ranked #4

Why it stands out:

  • Hosts one of the largest Lung Cancer Programs in the U.S., integrating pulmonology, thoracic surgery, oncology, radiology, and pathology.

  • Uses VATS, robotic-assisted lobectomies, and precision radiation (including SBRT, IMRT, VMAT, IGRT, and proton therapy) and runs extensive clinical trials and tumor board consultations.

Asian patient–friendly services

  • Known for offering medical translation in key Asian languages.

  • Includes EGFR mutation profiling in routine genomic testing—highly relevant for Asian populations.

5. Massachusetts General Hospital (Boston, MA) – Ranked #5

Why it stands out:

  • The Center for Thoracic Cancers excels in personalized surgical care for complex pulmonary tumors.

  • Advanced radiation techniques include IMRT, VMAT, SBRT, 4D CT, and respiratory-gated therapy.

  • A fast-rising research hub with approximately 1,200 active clinical trials.

Asian patient–friendly services 

  • Professional interpretation services in Mandarin, Cantonese, Korean, Japanese, and translated educational materials.

  • Participates in EGFR-targeted research programs and treats a high number of Asian you with cross-cultural support teams.

What This Means for Asian Patients

These top U.S. institutions combine globally recognized pulmonary cancer care with services designed for Asian patients language support, genetic therapy alignment, cultural understanding, and even remote coordination through telemedicine hubs.

How Medebound HEALTH Enables Access to U.S. Expertise and Top Pulmonary Cancer Treatment


Medebound HEALTH supports you by:

 Providing both written and video second opinion consultations from top U.S. doctors, as well as arranging on-site appointments with leading hospitals.

These top-tier hospital resources are excellent, but for many Asian patients, direct contact can present language and procedural barriers. Medebound’s core value lies in bridging these gaps, making world-class care more accessible and stress-free.

Compared to contacting a hospital’s international department directly, our appointment process is more efficient:

  • Second opinions can be completed within 1–2 weeks.

  • On-site appointments can be arranged within 3–4 weeks.

  • The average response time for the international departments of traditional hospitals is 4–6 weeks, while Medebound can shorten it to just 2–3 weeks.


For on-site visits, while a hospital’s international department typically provides medical translation, we go further offering additional assistance with daily life translation to help you navigate local services, daily communication, and cultural differences with ease.

We also coordinate all travel, accommodation, and communication logistics for a seamless treatment journey, allowing you to focus fully on your health.


Important Considerations:

 Insurance Coverage: Check with your insurance provider regarding coverage for second opinion consultations, as many may not cover the cost. 


Second Opinion Limitation: U.S. second opinion consultations are for reference purposes only. The physician-patient relationship is not formed with your remote physician. Remote consultations differ from in-person visits and are subject to limitations due to lack of direct in-person examination. As such you will need to understand Medebound HEALTH and the U.S. doctor are not liable for any treatment decisions made based on the second opinion, and accept the risks of relying on any information provided under this agreement. You will need to sign an agreement to confirm that you voluntarily request this service and understand its limitations.


Timeliness: Getting a second opinion early in your treatment journey, ideally before starting treatment, can be beneficial. 

Frequently Asked Questions (FAQ)

1. What makes pulmonary cancer treatment in the USA different from other countries? Top U.S. hospitals have access to the latest FDA-approved targeted therapies, immunotherapies, and minimally invasive surgical techniques. These treatments are often available years earlier than in other regions, which can significantly improve patient outcomes.


2. How can an international patient access a second opinion from a top U.S. pulmonary oncologist without traveling? 

Medebound HEALTH offers virtual second opinion services. Patients upload their medical records, imaging, and test results, which are reviewed by senior U.S. specialists. The written or video consultation is delivered directly to the patient and their local doctor.


3. What is the turnaround time for a second opinion through Medebound HEALTH? 

Medebound HEALTH typically delivers written or video second opinions within 1–2 weeks. By comparison, many U.S. hospital international departments require 4–6 weeks or more for the same process.


4. Can Medebound HEALTH also arrange in-person treatment in the USA? 

Yes. Medebound HEALTH coordinates on-site appointments at leading hospitals, usually within 3–4 weeks, along with assistance for visa arrangements, hospital admission, and daily life translation support.


5. What if the U.S. specialist recommends a treatment not available in my country? 

Medebound HEALTH can assist patients in arranging medical travel to the USA to receive advanced treatments, such as targeted therapy, immunotherapy, or robotic-assisted surgery.


6. Are the U.S. doctors who give second opinions through Medebound HEALTH senior-level specialists? 

Yes. Medebound HEALTH partners with senior specialists, often full professors or department heads, ensuring patients receive advice from the most experienced doctors in their field.


Your Next Step to Clarity for Online Second Opinion 

Don’t settle for uncertainty. Reach out to Medebound HEALTH today to request an online second opinion from top USA doctors, explore advanced lung cancer care options, and take control of your treatment journey with expert, patient-first support.


About Medebound HEALTH: Since 2016, we've helped thousands of affluent families mostly from Asia get personalized cancer remote second opinions from the top 1% of US hospitals through simple written opinion or video calls.  These are the same top doctors trained or active at top hospitals such as MD Anderson, Mayo Clinic, Memorial Sloan Kettering and Johns Hopkins, etc, you will get their expertise, their treatment suggestion, and their guidance - all from your home. No matter where you live, world-class cancer care is just a few steps away.


Contact Us to Get Started

WhatsApp: +1 718 213 8508

 

Submit the form: Click HERE we will get back within 4 hours Instant Chat: Click the chat button at the lower right corner of this page

 


Submit your case today and connect with MD Anderson experts through Medebound HEALTH.


Medebound HEALTH connects families to top U.S. pediatric epilepsy specialists, advanced medications, and personalized care without the need to travel abroad.

Disclaimer: 

We strive to maintain the accuracy and provide regular updates for the treatment information described in this article. However, treatment outcomes may vary between individuals. The information provided here is not intended as a diagnostic or treatment recommendation and should not replace the careful evaluation and advice of your attending physician.


Comments


Make Inquiries Now
If you or your loved ones would like to consult a top specialist in the US or consider traveling for care 

Thank You For Submitting. We will get back to you shortly.

Why Medebound HEALTH

1000+ US Physician Network

We know top doctors make a difference. Our consulting doctors are world-class physicians recognized by prestigious awards such as Castle Connolly Top Doctors, encompassing 70+ medical disciplines representing the Top 1% doctors of in the nation.

Top 20 US Hospitals

 Medebound HEALTH sends cases to the top doctors from the best medical institutions. These doctors are trained and teaching at top research hospitals, pioneering cutting-edge research, and advocating groundbreaking treatment regimens. 90% of our doctors are trained and worked at some of the country’s most elite institutions, such as Johns Hopkins Hospital, Boston Children’s Hospital, and the Hospital for Special Surgery.

bottom of page